Virginie Tardif - San Martin
@vtardifsm.bsky.social
Cardio-immunologist
Assistant Prof CPJ U1180-Paris Saclay
🧫🧪🧑🔬 🫀🐢
Former Chaire excellence Cardioimmuno U1096-Rouen
Former Instructor HIV-cTFh at Drexel university, Philly, PA
Former Research Associate Autoimmunity- Therapy Innovation, TSRI, La Jolla, CA
Assistant Prof CPJ U1180-Paris Saclay
🧫🧪🧑🔬 🫀🐢
Former Chaire excellence Cardioimmuno U1096-Rouen
Former Instructor HIV-cTFh at Drexel university, Philly, PA
Former Research Associate Autoimmunity- Therapy Innovation, TSRI, La Jolla, CA
Reposted by Virginie Tardif - San Martin
2️⃣ Using a cSCC model, we reveal that cancer cells change their IC ligand profile according to their epithelial/mesenchymal features, dictating the IC pathways involved in immune evasion: epithelial cancer cells via PD-1/L1 and mesenchymal cancer cells via CTLA-4/CD80 & TIGIT/CD155
November 21, 2024 at 3:52 PM
2️⃣ Using a cSCC model, we reveal that cancer cells change their IC ligand profile according to their epithelial/mesenchymal features, dictating the IC pathways involved in immune evasion: epithelial cancer cells via PD-1/L1 and mesenchymal cancer cells via CTLA-4/CD80 & TIGIT/CD155